Boenning & Scattergood, Inc. Acadia Pharmaceuticals Inc Transaction History

Boenning & Scattergood, Inc.

$622 Million
Q4 2022

A detailed history of Boenning & Scattergood, Inc. transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Boenning & Scattergood, Inc. holds 53,475 shares of ACAD stock, worth $912,818. This represents 0.21% of its overall portfolio holdings.

Number of Shares

53,475

Previous 30,260 76.72%

Holding current value

$912,818

Previous $495,000 161.62%

% of portfolio

0.21%

Previous 0.1%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 25, 2023	BUY	$14.2 - $18.63 $329,653 - $432,495	23,215 Added 76.72%	53,475 $1.3 Million
Q3 2022 Oct 11, 2022	SELL	$14.11 - $18.27 $2,822 - $3,654	-200 Reduced 0.66%	30,260 $495,000
Q2 2022 Jul 13, 2022	SELL	$13.01 - $27.22 $299,425 - $626,468	-23,015 Reduced 43.04%	30,460 $429,000
Q4 2021 Jan 18, 2022	SELL	$16.79 - $27.09 $6,716 - $10,836	-400 Reduced 0.74%	53,475 $1.25 Million
Q3 2021 Oct 21, 2021	SELL	$15.78 - $24.77 $78,900 - $123,850	-5,000 Reduced 8.49%	53,875 $894,000
Q2 2021 Jul 21, 2021	BUY	$19.4 - $27.42 $484,999 - $685,500	25,000 Added 73.8%	58,875 $1.44 Million
Q3 2020 Oct 21, 2020	BUY	$36.42 - $57.0 $14,568 - $22,800	400 Added 1.19%	33,875 $1.4 Million
Q1 2020 Apr 13, 2020	BUY	$31.65 - $46.87 $122,643 - $181,621	3,875 Added 13.09%	33,475 $1.41 Million
Q4 2019 Jan 15, 2020	BUY	$36.21 - $51.4 $108,630 - $154,200	3,000 Added 11.28%	29,600 $1.27 Million
Q2 2019 Jul 15, 2019	SELL	$23.32 - $28.12 $584,166 - $704,406	-25,050 Reduced 48.5%	26,600 $711,000
Q1 2019 Apr 22, 2019	BUY	$16.17 - $27.38 $37,999 - $64,343	2,350 Added 4.77%	51,650 $1.39 Million
Q4 2018 Jan 22, 2019	BUY	$14.32 - $22.92 $42,960 - $68,760	3,000 Added 6.48%	49,300 $797,000
Q3 2018 Oct 05, 2018	SELL	$13.03 - $21.81 $5,212 - $8,724	-400 Reduced 0.86%	46,300 $961,000
Q2 2018 Aug 13, 2018	BUY	$15.07 - $22.34 $703,769 - $1.04 Million	46,700 New	46,700 $713,000

Others Institutions Holding ACAD

# of Institutions

279

Shares Held

156M

Call Options Held

901K

Put Options Held

314K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.76B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boenning & Scattergood, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Boenning & Scattergood, Inc. with notifications on news.

Account

Boenning & Scattergood, Inc. Acadia Pharmaceuticals Inc Transaction History